| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net Income (Loss) Attributable to Parent | ||||||
-12,443 | -29,886 | -30,384 | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||||
Depreciation, Depletion and Amortization | ||||||
8,100 | 4,900 | 3,200 | ||||
Non-cash expenses related to convertible note | ||||||
0 | 0 | 1,123 | ||||
Share-based compensation expense | ||||||
12,807 | 2,241 | 665 | ||||
Loss on sale of fixed assets | ||||||
-93 | -76 | 0 | ||||
Amortization of debt issuance costs | ||||||
181 | 109 | 37 | ||||
Change in preferred and common stock warrant liabilities | ||||||
12,503 | 1,120 | 385 | ||||
Restructuring loss on write-off of fixed assets | ||||||
0 | 0 | 2,302 | ||||
Net change in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
27,454 | 9,045 | 2,702 | ||||
Inventories | ||||||
51,339 | 22,113 | 1,959 | ||||
Prepaid expenses and other assets | ||||||
2,362 | -325 | 795 | ||||
Accounts payable | ||||||
10,149 | 10,455 | 2,361 | ||||
Accrued expenses and other current liabilities | ||||||
2,743 | 3,798 | 464 | ||||
Long-term liabilities | ||||||
21 | 278 | 49 | ||||
Net cash used in operating activities | ||||||
-46,995 | -37,721 | -25,273 | ||||
Cash flows from investing activities: | ||||||
Purchases of property, plant and equipment | ||||||
23,795 | 22,228 | 7,908 | ||||
Proceeds from sale of fixed assets | ||||||
0 | 67 | 0 | ||||
Purchases of property, plant and equipment held for sale | ||||||
2,123 | 1,022 | 0 | ||||
Proceeds from sale of assets held for sale | ||||||
299 | 0 | 0 | ||||
Payment of security deposits | ||||||
545 | 59 | 207 | ||||
Net cash used in investing activities | ||||||
-26,164 | -23,242 | -8,115 | ||||
Cash flows from financing activities: | ||||||
Principal payments under finance lease obligations | ||||||
55 | 153 | 221 | ||||
Proceeds from issuance of common stock pursuant to the initial public offering, net of issuance costs | ||||||
254,868 | 0 | 0 | ||||
Proceeds from issuance of common stock pursuant to the secondary public offering, net of issuance costs | ||||||
37,394 | 0 | 0 | ||||
Proceeds from convertible note issuance | ||||||
0 | 0 | 10,000 | ||||
Proceeds from revolving credit line | ||||||
0 | 6,000 | 2,500 | ||||
Proceeds from term loan borrowing | ||||||
0 | 20,000 | 0 | ||||
Proceeds from equipment loan borrowing | ||||||
0 | 5,000 | 0 | ||||
Proceeds from payoff of notes receivable for restricted stock purchase | ||||||
0 | 951 | 0 | ||||
Repayments on revolving credit line | ||||||
0 | 2,500 | 0 | ||||
Repayment on term loan | ||||||
0 | 1,000 | 500 | ||||
Repayment of Missouri Note | ||||||
0 | 1,450 | 0 | ||||
Proceeds from exercise of stock options | ||||||
2,669 | 1,369 | 379 | ||||
Proceeds from restricted stock exercise | ||||||
0 | 2 | 0 | ||||
Payments of deferred offering costs | ||||||
0 | 2,415 | 0 | ||||
Debt issuance costs | ||||||
0 | 437 | 0 | ||||
Payment for repurchase of common stock | ||||||
0 | 514 | 0 | ||||
Net cash provided by (used in) financing activities | ||||||
294,876 | 76,199 | 55,425 | ||||
Net decrease in cash and cash equivalents | ||||||
221,717 | 15,236 | 22,037 | ||||
Supplemental disclosures of cash flow information: | ||||||
Cash paid during the period for: | ||||||
Interest | ||||||
3,019 | 924 | 269 | ||||
Taxes | ||||||
9 | 4 | 3 | ||||
Non-cash investing and financing activities: | ||||||
Capital lease obligations for the purchase of property, plant and equipment | ||||||
225 | 85 | 35 | ||||
Issuance of convertible preferred stock warrants in connection with debt | ||||||
0 | 248 | 0 | ||||
Non-cash additions to property, plant and equipment | ||||||
1,418 | 1,146 | 1,376 | ||||
Offering costs, accrued not yet paid | ||||||
0 | 745 | 0 | ||||
Reclassification of warrant liability to additional paid-in capital upon closing of the initial public offering | ||||||
14,421 | 0 | 0 | ||||
Conversion of convertible preferred stock to common stock upon initial public offering | ||||||
199,540 | 0 | 0 | ||||
Series H | ||||||
Proceeds from preferred stock offering, net of offering costs | ||||||
0 | 49,999 | 0 | ||||
Series G | ||||||
Proceeds from preferred stock offering, net of offering costs | ||||||
0 | 1,347 | 43,188 | ||||
Series F | ||||||
Proceeds from preferred stock offering, net of offering costs | ||||||
0 | 0 | 79 | ||||